Join
Live feed
·
INSIDERFilingvia Quantisnow
Intellia Therapeutics Inc. logo

EVP, Chief Scientific Officer Schultes Birgit C was granted 39,200 shares, increasing direct ownership by 40% to 137,733 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NTLA· Intellia Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NTLA (Intellia Therapeutics Inc.) and more on Quantisnow.